Incidence and Survival of Hepatocellular Carcinoma in Type 2 Diabetes Patients with Cirrhosis Who Were Treated with and without Metformin

PURPOSE: To evaluate metformin’s benefit on the incidence and survival of hepatocellular carcinoma (HCC) in cirrhosis with type 2 diabetes mellitus (T2DM) patients. PATIENTS AND METHODS: We conducted a retrospective study from 2006 to 2019. The patients were assigned to metformin exposure if they ad...

Descripción completa

Detalles Bibliográficos
Autores principales: Tangjarusritaratorn, Thanida, Tangjittipokin, Watip, Kunavisarut, Tada
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8043797/
https://www.ncbi.nlm.nih.gov/pubmed/33859487
http://dx.doi.org/10.2147/DMSO.S295753

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8043797/
https://www.ncbi.nlm.nih.gov/pubmed/33859487
http://dx.doi.org/10.2147/DMSO.S295753

Ejemplares similares